AI model combines gradient boosting and neural networks for drug sales predictions | News
One Russian pharmaceutical company has already expressed interest in the model. Earlier, US and Chinese bioinformaticians developed an AI model that ...
Новости GxP 2
Covers: HealthcareChina & Geopolitics
FDA to review AI tool that predicts drug‑induced liver injury, a leading cause of trial failures
... AI ‑based Drug Development Tool. The AI model is designed to predict drug‑induced liver injury – one of the main causes of clinical trial failures .